Ovarian feedback, mechanism of action and possible clinical implications

Human Reproduction Update

Volumn 12, Issue 5, 2006, Pages 557-571

  Messinisi, Ioannis E ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

Estrogen; FSH; LH; Ovarian feedback; Progesterone

Indexed keywords

AROMATASE INHIBITOR; CLOMIFENE CITRATE; ESTRADIOL; ETHINYLESTRADIOL; FOLLITROPIN; GESTAGEN; GONADORELIN; GONADOTROPIN; INHIBIN A; INHIBIN B; LUTEINIZING HORMONE; PROGESTERONE; STEROID; TAMOXIFEN;

ARTICLE; DRUG MECHANISM; DRUG RECEPTOR BINDING; FEEDBACK SYSTEM; FEMALE; FOLLICULAR PHASE; FOLLITROPIN RELEASE; GONADOTROPIN RELEASE; HORMONE ACTION; HUMAN; HYPOPHYSIS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LUTEAL PHASE; LUTEINIZING HORMONE RELEASE; MENOPAUSE; NEGATIVE FEEDBACK; OVARY; OVARY FUNCTION; OVULATION INDUCTION; POSITIVE FEEDBACK; PRIORITY JOURNAL; REGULATORY MECHANISM;

ESTRADIOL; FEEDBACK, BIOCHEMICAL; FEMALE; GENITAL DISEASES, FEMALE; GONADAL HORMONES; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS, PITUITARY; HUMANS; INHIBINS; MENOPAUSE; MENSTRUAL CYCLE; PITUITARY GLAND; PROGESTERONE;

EID: 33748157097     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dml020     Document Type: Article

References (221)

1. Adams JM, Taylor AE, Schoenfeld DA, Crowley WF Jr and Hall JE (1994) The midcycle gonadotropin surge in normal women occurs in the face of an unchanging gonadotropin-releasing hormone pulse frequency. J Clin Endocrinol Metab 79,858-864.
2. Albano C, Felberbaum RE, Smitz J, Riethmuller-Winzen H, Engel J, Diedrich K and Devroey P (2000) Ovarian stimulation with HMG: Results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group. Hum Reprod 153,526-531.
3. Alexandris E, Milingos S, Kollios G, Seferiadis K, Lolis D and Messinis IE (1997) Changes in gonadotrophin response to gonadotrophin releasing hormone in normal women following bilateral ovariectomy. Clin Endocrinol (Oxf) 47,721-726.
4. Attardi B, Keeping HS, Winters SJ, Kotsuji F and Troen P (1991) Comparison of the effects of cycloheximide and inhibin on the gonadotropin subunit messenger ribonucleic acids. Endocrinology 128,119-125.
5. Attardi B, Vaughan J and Vale W (1992) Regulation of FSH beta messenger ribonucleic acid levels in the rat by endogenous inhibin. Endocrinology 130,557-559.
6. Baccarelli A, Morpurgo PS, Corsi A, Vaghi I, Fanelli M, Cremonesi G, Vaninetti S, Beck-Peccoz P and Spada A (2001) Activin A serum levels and aging of the pituitary-gonadal axis: A cross-sectional study in middle-aged and elderly healthy subjects. Exp Gerontol 36,1403-1412.
7. Balen AH, Er J, Rafferty B and Rose M (1995a) In vitro bioactivity of gonadotrophin surge attenuating factor is not affected by an antibody to human inhibin. J Reprod Fertil 104,285-289.
8. Balen AH, Conway GS, Kaltsas G, Techatrasak Y, Manning PJ, West C and Jacobs HS (1995b) Polycystic ovary syndrome: The spectrum of the disorder in 1741 patients. Hum Reprod 10,2107-2111.
9. Batista MC, Cartledge TP, Zellmer AW, Nieman LK, Merriam GR and Loriaux DL (1992) Evidence for a critical role of progesterone in the regulation of the midcycle gonadotropin surge and ovulation. J Clin Endocrinol Metab 74,565-570.
10. Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, Bustion S, Loumaye E and Fauser BC (2003) Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. J Clin Endocrinol Metab 88,4186-4192.
11. Bicsak TA, Tucker EM, Cappel S, Vaughan J, Rivier J, Vale W and Hsueh AJ (1986) Hormonal regulation of granulosa cell inhibin biosynthesis. Endocrinology 119,2711-2719.
12. Bilezikjian LM, Vaughan JM and Vale WW (1993) Characterization and the regulation of inhibin/activin subunit proteins of cultured rat anterior pituitary cells. Endocrinology 133,2545-2553.
13. Bilezikjian LM, Corrigan AZ and Vale WW (1994) Activin-B, inhibin-B and follistatin as autocrine/paracrine factors of the rat anterior pituitary. In Burger HG (ed.), Challenges in Endocrinology and Modern Medicine, Vol. 3. Ares Serono Symposium, Rome, Italy, pp. 81-99.
14. Borm G and Mannaerts B (2000) Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: Results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Hum Reprod 15,1490-1498.
15. Buckler HM, Bangah M, Healy DL and Burger HG (1992) Vaginal progesterone administration in physiological doses normalizes raised luteinizing hormone levels in patients with polycystic ovarian syndrome. Gynecol Endocrinol 6,275-282.
16. Burger HG, Cahir N, Robertson DM, Groome NP, Dudley E, Green A and Dennerstein L (1998) Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Clin Endocrinol (Oxf) 49,550.
17. Burger HG, Dudley E, Mamers P, Groome N and Robertson DM (2000) Early follicular phase serum FSH as a function of age: The roles of inhibin B, inhibin A and estradiol. Climacteric 3,17-24.
18. Burger HG, Dudley EC, Robertson DM and Dennerstein (2002) Hormonal changes in the menopause transition. Recent Prog Horm Res 57,257-275.
19. Byrne B, Fowler PA, Fraser M, Culler MD and Templeton A (1995) Gonadotropin surge-attenuating factor bioactivity in serum from superovulated women is not blocked by inhibin antibody. Biol Reprod 52,88-95.
20. Byrne B, Fowler PA and Templeton A (1996) Role of progesterone and nonsteroidal ovarian factors in regulating gonadotropin-releasing hormone self-priming in vitro. J Clin Endocrinol Metab 81,1454-1459.
21. Chakravarti S, Collins WP, Newton JR, Oram DH and Studd JW (1977) Endocrine changes and symptomatology after oophorectomy in premenopausal women. Br J Obstet Gynaecol 84,769-775.
22. Chang RJ and Jaffe RB (1978) Progesterone effects on gonadotropin release in women pretreated with estradiol. J Clin Endocrinol Metab 47,119-125.
23. Chappell PE, Schneider JS, Kim P, Xu M, Lydon JP, O'Malley BW and Levine JE (1999) Absence of gonadotropin surges and gonadotropin-releasing hormone self-priming in ovariectomized (OVX), estrogen (E2)-treated, progesterone receptor knockout (PRKO) mice. Endocrinology 140,3653-3658.
24. Christin-Maitre S, Taylor AE, Khoury RH, Hall JE, Martin KA, Smith PC, Albanese C, Jameson JL, Crowley WF Jr and Sluss PM (1996) Homologous in vitro bioassay for follicle-stimulating hormone (FSH) reveals increased FSH biological signal during the mid- to late luteal phase of the human menstrual cycle. J Clin Endocrinol Metab 81,2080-2088.
25. Corrigan AZ, Bilezikjian LM, Carroll RS, Bald LN, Schmelzer CH, Fendly BM, Mason AJ, Chin WW, Schwall RH and Vale W (1991) Evidence for an autocrine role of activin B within rat anterior pituitary cultures. Endocrinology 128,1682-1684.
26. Dafopoulos K, Kotsovassilis CG, Milingos S, Kallitsaris A, Galazios G, Zintzaras E, Sotiros P and Messinis IE (2004a) Changes in pituitary sensitivity to GnRH in estrogen-treated post-menopausal women: Evidence that gonadotrophin surge attenuating factor plays a physiological role. Hum Reprod 19,1985-1992.
27. Dafopoulos KC, Kotsovassilis CP, Milingos SD, Kallitsaris AT, Georgadakis GS, Sotiros PG and Messinis IE (2004b) FSH and LH responses to GnRH after ovariectomy in postmenopausal women. Clin Endocrinol (Oxf) 60,120-124.
28. Dafopoulos K, Mademtzis I, Vanakara P, Kallitsaris A, Stamatiou G, Kotsovassilis C and Messinis IE (2006) Evidence that termination of the estradiol-induced luteinizing hormone surge in women is regulated by ovarian factors. J Clin Endocrinol Metab 91,641-645.
29. Danforth DR and Cheng CY (1995) Purification of a candidate gonadotropin surge inhibiting factor from porcine follicular fluid. Endocrinology 136,1658-1665.
30. Danforth DR, Elkind-Hirsch K and Hodgen GD (1990) In vivo and in vitro modulation of gonadotropin-releasing hormone metabolism by estradiol and progesterone. Endocrinology 127,319-324.
31. Danforth DR, Arbogast LK, Mroueh J, Kim MH, Kennard EA, Seifer DB and Friedman CI (1998) Dimeric inhibin: A direct marker of ovarian aging. Fertil Steril 70,119-123.
32. Daw E (1974) Luteinising hormone (LH) changes in women undergoing artificial menopause. Curr Med Res Opin 2,256-259.
33. de Kretser DM, Hedger MP, Loveland KL and Phillips DJ (2002) Inhibins, activins and follistatin in reproduction. Hum Reprod Update 8,529-541.
34. de Vet A, Laven JS, de Jong FH, Themmen AP and Fauser BC (2002) Antimullerian hormone serum levels: A putative marker for ovarian aging. Fertil Steril 77,357-362.
35. Djahanbakhch O, McNeilly AS, Warner PM, Swanston IA and Baird DT (1984) Changes in plasma levels of prolactin, in relation to those of FSH, oestradiol, androstenedione and progesterone around the preovulatory surge of LH in women. Clin Endocrinol (Oxf) 20,463-472.
36. Engel JB, Ludwig M, Felberbaum R, Albano C, Devroey P and Diedrich K (2002) Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: A suitable approach to 'friendly IVF'? Hum Reprod 17,2022-2026.
37. European and Middle East Orgalutran Study Group (2001) Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod 16,644-651.
38. Evans WS, Boykin BJ, Kaiser DL, Borges JL and Thorner MO (1983) Biphasic luteinizing hormone secretion in response to gonadotropin-releasing hormone during continuous perifusion of dispersed rat anterior pituitary cells: Changes in total release and the phasic components during the estrous cycle. Endocrinology 112,535-542.
39. Evans NP, Dahl GE, Padmanabhan V, Thrun LA and Karsch FJ (1997) Estradiol requirements for induction and maintenance of the gonadotropin-releasing hormone surge: Implications for neuroendocrine processing of the estradiol signal. Endocrinology 138,5408-5414.
40. Evans LW, Muttukrishna S and Groome NP (1998) Development, validation and application of an ultra-sensitive two-site enzyme immunoassay for human follistatin. J Endocrinol 156,275-282.
41. Fanchin R, Cunha-Filho JS, Schonauer LM, Kadoch IJ, Cohen-Bacri P and Frydman R (2003a) Coordination of early antral follicles by luteal estradiol administration provides a basis for alternative controlled ovarian hyperstimulation regimens. Fertil Steril 79,316-321.
42. Fanchin R, Salomon L, Castelo-Branco A, Olivennes F, Frydman N and Frydman R (2003b) Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists. Hum Reprod 18,2698-2703.
43. Farnworth PG, Robertson DM, de Kretser DM and Burger HG (1988) Effects of 31 kilodalton bovine inhibin on follicle-stimulating hormone and luteinizing hormone in rat pituitary cells in vitro: Actions under basal conditions. Endocrinology 122,207-213.
44. Farnworth PG, Thean E, Robertson DM and Schwartz J (1995) Ovine anterior pituitary production of follistatin in vitro. Endocrinology 136,4397-4406.
45. Felberbaum RE, Albano C, Ludwig M, Riethmuller-Winzen H, Grigat M, Devroey P and Diedrich K (2000) Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: A prospective uncontrolled phase III study. Hum Reprod 15,1015-1020.
46. Ferin M, Dyrenfurth I, Cowchock S, Warren M and Wiele RL (1974) Active immunization to 17 beta-estradiol and its effects upon the reproductive cycle of the rhesus monkey. Endocrinology 94,765-776.
47. Ferin M, Rosenblatt H, Carmel PW, Antunes JL and Vande Wiele RL (1979) Estrogen-induced gonadotropin surges in female rhesus monkeys after pituitary stalk section. Endocrinology 104,50-52.
48. Filicori M, Santoro N, Merriam GR and Crowley WF Jr (1986) Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocrinol Metab 62,1136-1144.
49. Foster DL and Ryan KD (1979) Endocrine mechanisms governing transition into adulthood: A marked decrease in inhibitory feedback action of estradiol on tonic secretion of luteinizing hormone in the lamb during puberty. Endocrinology 105,896-904.
50. Fowler PA and Templeton A (1996) The nature and function of putative gonadotropin surge-attenuating/inhibiting factor (GnSAF/IF). Endocr Rev 17,103-120.
51. Fowler PA, Messinis IE and Templeton AA (1990) Inhibition of LHRH-induced LH and FSH release by gonadotrophin surge-attenuating factor (GnSAF) from human follicular fluid. J Reprod Fertil 90,587-594.
52. Fowler PA, Sorsa T, Harris WJ, Knight PG and Mason HD (2001) Relationship between follicle size and gonadotrophin surge attenuating factor (GnSAF) bioactivity during spontaneous cycles in women. Hum Reprod 16,1353-1358.
53. Fowler PA, Sorsa-Leslie T, Cash P, Dunbar B, Melvin W, Wilson Y, Mason HD and Harris W (2002) A 60-66 kDa protein with gonadotrophin surge attenuating factor bioactivity is produced by human ovarian granulosa cells. Mol Hum Reprod 8,823-832.
54. Fowler PA, Sorsa-Leslie T, Harris W and Mason HD (2003) Ovarian gonadotrophin surge-attenuating factor (GnSAF): Where are we after 20 years of research? Reproduction 126,689-699.
55. Fraser HM (1988) LHRH analogues: Their clinical physiology and delivery systems. Baillieres Clin Obstet Gynaecol 2,639-658.
56. Geiger JM, Plas-Roser S and Aron C (1980) Mechanisms of ovulation in female rats treated with FSH at the beginning of the estrous cycle: changes in pituitary responsiveness to luteinizing hormone releasing hormone (LHRH). Biol Reprod 22,837-845.
57. Gill S, Sharpless JL, Rado K and Hall JE (2002) Evidence that GnRH decreases with gonadal steroid feedback but increases with age in postmenopausal women. J Clin Endocrinol Metab 87,2290-2296.
58. Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mather JP and McNeilly AS (1996) Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 81,1401-1405.
59. Hall JE, Schoenfeld DA, Martin KA and Crowley WF Jr (1992) Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition. J Clin Endocrinol Metab 74,600-607.
60. Hall JE, Lavoie HB, Marsh EE and Martin KA (2000) Decrease in gonadotropin-releasing hormone (GnRH) pulse frequency with aging in postmenopausal women. J Clin Endocrinol Metab 85,1794-1800.
61. Hoff JD, Lasley BL, Wang CF and Yen SSC (1977) The two pools of pituitary gonadotropin: Regulation during the menstrual cycle. J Clin Endocrinol Metab 44,302-312.
62. Hoff JD, Lasley BL and Yen SSC (1979) The functional relationship between priming and releasing actions of luteinizing hormone-releasing hormone. J Clin Endocrinol Metab 49,8-11.
63. Hoff JD, Quigley ME and Yen SSC (1983) Hormonal dynamics at midcycle: A reevaluation. J Clin Endocrinol Metab 57,792-796.
64. Huirne JA, van Loenen AC, Schats R, McDonnell J, Hompes PG, Schoemaker J, Homburg R and Lambalk CB (2005) Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: Optimal changes in LH and progesterone for clinical pregnancy. Hum Reprod 20,359-367.
65. Humaidan P, Bungum L, Bungum M and Andersen CY (2002) Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation. Hum Reprod 17,2016-2021.
66. Johansson ED and Wide L (1969) Periovulatory levels of plasma progesterone and luteinizing hormone in women. Acta Endocrinol (Copenh) 62,82-88.
67. Judd S, Terry A, Petrucco M and White G (1992) The source of pulsatile secretion of progesterone during the human follicular phase. J Clin Endocrinol Metab 74,299-305.
68. Karande VC, Scott RT Jr and Archer DF (1990) The relationship between serum estradiol-17 beta concentrations and induced pituitary luteinizing hormone surges in postmenopausal women. Fertil Steril 54,217-221.
69. Karligiotou E, Kollia P, Kallitsaris A and Messinis IE (2006) Expression of human serum albumin (HSA) mRNA in human granulosa cells: Potential correlation of the 95 amino acid long carboxyl terminal of HSA to gonadotrophin surge-attenuating factor. Hum Reprod 21,645-650.
70. Karsch FJ, Weick RF, Butler WR, Dierschke DJ, Krey LC, Weiss G, Hotchkiss J, Yamaji T and Knobil E (1973) Induced LH surges in the rhesus monkey: Strength-duration characteristics of the estrogen stimulus. Endocrinology 92,1740-1747.
71. Kazem R, Messinis IE, Fowler P, Groome NP, Knight PG and Templeton AA (1996) Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women. Hum Reprod 11,2585-2590.
72. Kelner KL and Peck EJ Jr (1984) Differential sensitivity of estrogen target tissues: Implications for estrogen regulation of serum luteinizing hormone. J Neurosci Res 11,79-89.
73. Kettel LM, DePaolo LV, Morales AJ, Apter D, Ling N and Yen SSC (1996) Circulating levels of follistatin from puberty to menopause. Fertil Steril 65,472-476.
74. Keye WR Jr and Jaffe RB (1975) Strength-duration characteristics of estrogen effects on gonadotropin response to gonadotropin-releasing hormone in women. I. Effects of varying duration of estradiol administration. J Clin Endocrinol Metab 41,1003-1008.
75. Khoury RH, Wang QF, Crowley WF Jr, Hall JE, Schneyer AL, Toth T, Midgley AR Jr and Sluss PM (1995) Serum follistatin levels in women: Evidence against an endocrine function of ovarian follistatin. J Clin Endocrinol Metab 80,1361-1368.
76. Kishi H, Okada T, Otsuka M, Watanabe G, Taya K and Sasamoto S (1996) Induction of superovulation by immunoneutralization of endogenous inhibin through the increase in the secretion of follicle-stimulating hormone in the cyclic golden hamster. J Endocrinol 151,65-75.
77. Klein NA, Illingworth PJ, Groome NP, McNeilly AS, Battaglia DE and Soules MR (1996) Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: A study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab 81,2742-2745.
78. Klein NA, Houmard BS, Hansen KR, Woodruff TK, Sluss PM, Bremner WJ and Soules MR (2004) Age-related analysis of inhibin A, inhibin B, and activin a relative to the intercycle monotropic follicle-stimulating hormone rise in normal ovulatory women. J Clin Endocrinol Metab 89,2977-2981.
79. Knobil E (1988) The neuroendocrine control of ovulation. Hum Reprod 3,469-472.
80. Kolibianakis EM, Zikopoulos K, Schiettecatte J, Smitz J, Tournaye H, Camus M, Van Steirteghem AC and Devroey P (2004) Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF. Hum Reprod 19,2490-2496.
81. Koppenaal DW, Tijssen AM and de Koning J (1992) The effect of gonadotrophin surge-inhibiting factor on the self-priming action of gonadotrophin-releasing hormone in female rats in vitro. J Endocrinol 134,427-436.
82. Kuhl H, Gahn G, Romberg G, Marz W and Taubert HD (1985) A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters. I. Effects upon sexual hormone levels. Contraception 31,583-593.
83. Laatikainen T, Raisanen I, Tulenheimo A and Salminen K (1985) Plasma beta-endorphin and the menstrual cycle. Fertil Steril 44,206-209.
84. Laborde N, Carril M, Cheviakoff S, Croxatto HD, Pedroza E and Rosner JM (1976) The secretion of progesterone during the periovulatory period in women with certified ovulation. J Clin Endocrinol Metab 43,1157-1163.
85. Lachelin GC and Yen SSC (1978) Biphasic change in pituitary capacity induced by estrogen in hypogonadal women. J Clin Endocrinol Metab 46,369-373.
86. Lambalk CB, de Boer L, Schoute E, Popp-Snyders C and Schoemaker J (1997) Post-menopausal and chronological age have divergent effects on pituitary and hypothalamic function in episodic gonadotrophin secretion. Clin Endocrinol (Oxf) 46,439-443.
87. Landgren BM, Aedo AR, Nunez M, Cekan SZ and Diczfalusy E (1977) Studies on the pattern of circulating steroids in the normal menstrual cycle. 4. Periovulatory changes in relation to the LH surge. Acta Endocrinol (Copenh) 84,620-632.
88. Lasley BL, Wang CF and Yen SSC (1975) The effects of estrogen and progesterone on the functional capacity of the gonadotrophs. J Clin Endocrinol Metab 41,820-826.
89. Laughlin GA, Barrett-Connor E, Kritz-Silverstein D and von Muhlen D (2000) Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: The Rancho Bernardo Study. J Clin Endocrinol Metab 85,645-651.
90. Laws SC, Webster JC and Miller WL (1990) Estradiol alters the effectiveness of gonadotropin-releasing hormone (GnRH) in ovine pituitary cultures: GnRH receptors versus responsiveness to GnRH. Endocrinology 127,381-386.
91. Le Nestour E, Marraoui J, Lahlou N, Roger M, de Ziegler D and Bouchard P (1993) Role of estradiol in the rise in follicle-stimulating hormone levels during the luteal-follicular transition. J Clin Endocrinol Metab 77,439-442.
92. Lee SJ, Lenton EA, Sexton L and Cooke ID (1988) The effect of age on the cyclical patterns of plasma LH, FSH, oestradiol and progesterone in women with regular menstrual cycles. Hum Reprod 3,851-855.
93. Lee WS, Smith MS and Hoffman GE (1990) Progesterone enhances the surge of luteinizing hormone by increasing the activation of luteinizing hormone-releasing hormone neurons. Endocrinology 127,2604-2606.
94. Legan SJ and Tsai HW (2003) Oestrogen receptor-alpha and - beta immunoreactivity in gonadotropin-releasing hormone neurones after ovariectomy and chronic exposure to oestradiol. J Neuroendocrinol 15,1164-1170.
95. Leroy I, d'Acremont M, Brailly-Tabard S, Frydman R, de Mouzon J and Bouchard P (1994) A single injection of a gonadotropin-releasing hormone (GnRH) antagonist (Cetrorelix) postpones the luteinizing hormone (LH) surge: Further evidence for the role of GnRH during the LH surge. Fertil Steril 62,461-467.
96. Lind T, Cameron EH and Hunter WM (1978) Serum prolactin, gonadotrophin and oestrogen levels in women receiving hormone replacement therapy. Br J Obstet Gynaecol 85,138-141.
97. Ling N, Ying SY, Ueno N, Shimasaki S, Esch F, Hotta M and Guillemin R (1986) A homodimer of the beta-subunits of inhibin A stimulates the secretion of pituitary follicle stimulating hormone. Biochem Biophys Res Commun 138,1129-1137.
98. Liu ZH, Shintani Y, Wakatsuki M, Sakamoto Y, Harada K, Zhang CY and Saito S (1996a) Regulation of immunoreactive activin A secretion from cultured rat anterior pituitary cells. Endocr J 43,39-44.
99. Liu ZH, Shintani Y, Sakamoto Y, Harada K, Zhang CY, Fujinaka Y, Abe M, Goto T and Saito S (1996b) Effects of LHRH, FSH and activin A on follistatin secretion from cultured rat anterior pituitary cells. Endocr J 43,321-327.
100. Liu JH and Yen SSC (1983) Induction of midcycle gonadotropin surge by ovarian steroids in women: A critical evaluation. J Clin Endocrinol Metab 57,797-802.
101. Lobo RA, Granger L, Goebelsmann U and Mishell DR Jr (1981) Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO. J Clin Endocrinol Metab 52,156-158.
102. Loughlin JS, Naddaff PG and Badger TM (1984) LH responses to LHRH in perifused pituitary cell culture: Sex differences in the rat. Am J Physiol 246,145-152.
103. Lutjen PJ, Findlay JK, Trounson AO, Leeton JF and Chan LK (1986) Effect on plasma gonadotropins of cyclic steroid replacement in women with premature ovarian failure. J Clin Endocrinol Metab 62,419-423.
104. Mais V, Cetel NS, Muse KN, Quigley ME, Reid RL and Yen SSC (1987) Hormonal dynamics during luteal-follicular transition. J Clin Endocrinol Metab 64,1109-1114.
105. March CM, Goebelsmann U, Nakamura RM and Mishell DR Jr (1979) Roles of estradiol and progesterone in eiliciting the midcycle luteinizing hormone and follicle-stimulating hormone surges. J Clin Endocrinol Metab 49,507-513.
106. Marshall JC and Kelch RP (1986) Gonadotropin-releasing hormone: Role of pulsatile secretion in the regulation of reproduction. N Engl J Med 315,1459-1468.
107. Mather JP, Woodruff TK and Krummen LA (1992) Paracrine regulation of reproductive function by inhibin and activin. Proc Soc Exp Biol Med 201,1-15.
108. McCartney CR, Gingrich MB, Hu Y, Evans WS and Marshall JC (2002) Hypothalamic regulation of cyclic ovulation: Evidence that the increase in gonadotropin-releasing hormone pulse frequency during the follicular phase reflects the gradual loss of the restraining effects of progesterone. J Clin Endocrinol Metab 87,2194-2200.
109. McConnell DS, Wang Q, Sluss PM, Bolf N, Khoury RH, Schneyer AL, Midgley AR Jr, Reame NE, Crowley WF Jr and Padmanabhan V (1998) A two-site chemiluminescent assay for activin-free follistatin reveals that most follistatin circulating in men and normal cycling women is in an activin-bound state. J Clin Endocrinol Metab 83,851-858.
110. McLachlan RI, Dahl KD, Bremner WJ, Schwall R, Schmelzer CH, Mason AJ and Steiner RA (1989) Recombinant human activin-A stimulates basal FSH and GnRH-stimulated FSH and LH release in the adult male macaque, Macaca fascicularis. Endocrinology 125,2787-2789.
111. McNatty KP, Makris A, DeGrazia C, Osathanondh R and Ryan KJ (1979a) The production of progesterone, androgens, and estrogens by granulosa cells, thecal tissue, and stromal tissue from human ovaries in vitro. J Clin Endocrinol Metab 49,687-699.
112. McNatty KP, Smith DM, Makris A, Osathanondh R and Ryan KJ (1979b) The microenvironment of the human antral follicle: Interrelationships among the steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo and in vitro. J Clin Endocrinol Metab 49,851-860.
113. Messinis IE (2003) Modulatory effect of the ovary on LH secretion. Ann N Y Acad Sci 997,35-41.
114. Messinis IE (2005) Ovulation induction: A mini review. Hum Reprod 20,2688-2697.
115. Messinis IE and Templeton A (1986) The effect of pulsatile follicle stimulating hormone on the endogenous luteinizing hormone surge in women. Clin Endocrinol (Oxf) 25,633-640.
116. Messinis IE and Templeton AA (1987a) Endocrine and follicle characteristics of cycles with and without endogenous luteinizing hormone surges during superovulation induction with pulsatile follicle-stimulating hormone. Hum Reprod 2,11-16.
117. Messinis IE and Templeton AA (1987b) Disparate effects of endogenous and exogenous oestradiol on luteal phase function in women. J Reprod Fertil 79,549-554.
118. Messinis IE and Templeton AA (1988a) The endocrine consequences of multiple folliculogenesis. J Reprod Fertil Suppl 36,27-37.
119. Messinis IE and Templeton A (1988b) Blockage of the positive feedback effect of oestradiol during prolonged administration of clomiphene citrate to normal women. Clin Endocrinol (Oxf) 29,509-516.
120. Messinis IE and Templeton AA (1989) Pituitary response to exogenous LHRH in superovulated women. J Reprod Fertil 87,633-639.
121. Messinis IE and Templeton AA (1990) Effects of supraphysiological concentrations of progesterone on the characteristics of the oestradiol-induced gonadotrophin surge in women. J Reprod Fertil 88,513-519.
122. Messinis IE and Templeton AA (1991) Evidence that gonadotrophin surge-attenuating factor exists in man. J Reprod Fertil 92,217-223.
123. Messinis IE, Templeton A and Baird DT (1985) Endogenous luteinizing hormone surge during superovulation induction with sequential use of clomiphene citrate and pulsatile human menopausal gonadotropin. J Clin Endocrinol Metab 61,1076-1080.
124. Messinis IE, Templeton A and Baird DT (1986) Endogenous luteinizing hormone surge in women during induction of multiple follicular development with pulsatile follicle stimulating hormone. Clin Endocrinol (Oxf) 24,193-201.
125. Messinis IE, Hirsch P and Templeton AA (1991) Follicle stimulating hormone stimulates the production of gonadotrophin surge attenuating factor (GnSAF) in vivo. Clin Endocrinol (Oxf) 35,403-407.
126. Messinis IE, Mademtzis I, Zikopoulos K, Tsahalina E, Seferiadis K, Tsolas O and Templeton AA (1992) Positive feedback effect of oestradiol in superovulated women. Hum Reprod 7,469-474.
127. Messinis IE, Lolis D, Papadopoulos L, Tsahalina T, Papanikolaou N, Seferiadis K and Templeton AA (1993a) Effect of varying concentrations of follicle stimulating hormone on the production of gonadotrophin surge attenuating factor (GnSAF) in women. Clin Endocrinol (Oxf) 39,45-50.
128. Messinis IE, MacTavish A and Templeton AA (1993b) Activity of gonadotrophin surge-attenuating factor during the luteal phase in superovulated women. J Reprod Fertil 97,271-275.
129. Messinis IE, Koutsoyiannis D, Milingos S, Tsahalina E, Seferiadis K, Lolis D and Templeton AA (1993c) Changes in pituitary response to GnRH during the luteal-follicular transition of the human menstrual cycle. Clin Endocrinol (Oxf) 38,159-163.
130. Messinis IE, Lolis D, Zikopoulos K, Tsahalina E, Seferiadis K and Templeton AA (1994) Effect of an increase in FSH on the production of gonadotrophin-surge-attenuating factor in women. J Reprod Fertil 101,689-695.
131. Messinis IE, Lolis D, Zikopoulos K, Milingos S, Kollios G, Seferiadis K and Templeton AA (1996) Effect of follicle stimulating hormone or human chorionic gonadotrophin treatment on the production of gonadotrophin surge attenuating factor (GnSAF) during the luteal phase of the human menstrual cycle. Clin Endocrinol (Oxf) 44,169-175.
132. Messinis IE, Milingos S, Zikopoulos K, Hasiotis G, Seferiadis K and Lolis D (1998) Luteinizing hormone response to gonadotrophin-releasing hormone in normal women undergoing ovulation induction with urinary or recombinant follicle stimulating hormone. Hum Reprod 13,2415-2420.
133. Messinis IE, Papageorgiou I, Milingos S, Asprodini E, Kollios G and Seferiadis K (2001) Oestradiol plus progesterone treatment increases serum leptin concentrations in normal women. Hum Reprod 16,1827-1832.
134. Messinis IE, Milingos S, Alexandris E, Mademtzis I, Kollios G and Seferiadis K (2002) Evidence of differential control of FSH and LH responses to GnRH by ovarian steroids in the luteal phase of the cycle. Hum Reprod 17,299-303.
135. Messinis IE, Loutradis D, Domali E, Kotsovassilis CP, Papastergiopoulou L, Kallitsaris A, Drakakis P, Dafopoulos K and Milingos S (2005) Alternate day and daily administration of GnRH antagonist may prevent premature luteinization to a similar extent during FSH treatment. Hum Reprod 20,3192-3197.
136. Micevych P, Sinchak K, Mills RH, Tao L, LaPolt P and Lu JK (2003) The luteinizing hormone surge is preceded by an estrogen-induced increase of hypothalamic progesterone in ovariectomized and adrenalectomized rats. Neuroendocrinology 78,29-35.
137. Miro F and Aspinall LJ (2005) The onset of the initial rise in follicle-stimulating hormone during the human menstrual cycle. Hum Reprod 20,96-100.
138. Mitchner NA, Garlick C and Ben-Jonathan N (1998) Cellular distribution and gene regulation of estrogen receptors alpha and beta in the rat pituitary gland. Endocrinology 139,3976-3983.
139. Mitwally MF and Casper RF (2001) Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 75,305-309.
140. Miyake A, Tasaka K, Kawamura Y, Sakumoto T and Aono T (1982) Progesterone facilitates the LRH releasing action of oestrogen. Acta Endocrinol (Copenh) 101,321-324.
141. Miyake A, Tasaka K, Sakumoto T, Kawamura Y and Aono T (1983) Estrogen induces the release of luteinizing hormone-releasing hormone in normal cyclic women. J Clin Endocrinol Metab 56,1100-1102.
142. Moenter SM, Caraty A, Locatelli A and Karsch FJ (1991) Pattern of gonadotropin-releasing hormone (GnRH) secretion leading up to ovulation in the ewe: Existence of a preovulatory GnRH surge. Endocrinology 129,1175-1182.
143. Molskness TA, Woodruff TK, Hess DL, Dahl KD and Stouffer RL (1996) Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys. J Clin Endocrinol Metab 81,4002-4006.
144. Monroe SE, Jaffe RB and Midgley AR Jr (1972a) Regulation of human gonadotropins. XII. Increase in serum gonadotropins in response to estradiol. J Clin Endocrinol Metab 34,342-347.
145. Monroe SE, Jaffe RB and Midgley AR Jr (1972b) Regulation of human gondotropins. 13. Changes in serum gonadotropins in menstruating women in response to oophorectomy. J Clin Endocrinol Metab 34,420-422.
146. Muttukrishna S and Knight PG (1991) Inverse effects of activin and inhibin on the synthesis and secretion of FSH and LH by ovine pituitary cells in vitro. J Mol Endocrinol 6,171-178.
147. Muttukrishna S, Fowler PA, George L, Groome NP and Knight PG (1996) Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy. J Clin Endocrinol Metab 81,3328-3334.
148. Muttukrishna S, Child T, Lockwood GM, Groome NP, Barlow DH and Ledger WL (2000) Serum concentrations of dimeric inhibins, activin A, gonadotrophins and ovarian steroids during the menstrual cycle in older
149. Muttukrishna S, Sharma S, Barlow DH, Ledger W, Groome N and Sathanandan M (2002) Serum inhibins, estradiol, progesterone and FSH in surgical menopause: A demonstration of ovarian pituitary feedback loop in women. Hum Reprod 17,2535-2539.
150. Muttukrishna S, Tannetta D, Groome N and Sargent I (2004) Activin and follistatin in female reproduction. Mol Cell Endocrinol 225,45-56.
151. Nakai Y, Plant TM, Hess DL, Keogh EJ and Knobil E (1978) On the sites of the negative and positive feedback actions of estradiol in the control of gonadotropin secretion in the rhesus monkey. Endocrinology 102,1008-1014.
152. Nakamura T, Takio K, Eto Y, Shibai H, Titani K and Sugino H (1990) Activin-binding protein from rat ovary is follistatin. Science 247,836-838.
153. Nippoldt TB, Reame NE, Kelch RP and Marshall JC (1989) The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle. J Clin Endocrinol Metab 69,67-76.
154. Padmanabhan V, Battaglia D, Brown MB, Karsch FJ, Lee JS, Pan W, Phillips DJ and Van Cleeff J (2002) Neuroendocrine control of follicle-stimulating hormone (FSH) secretion. II. Is follistatin-induced suppression of FSH secretion mediated via changes in activin availability and does it involve changes in gonadotropin-releasing hormone secretion? Biol Reprod 66,1395-1402.
155. Pappa A, Seferiadis K, Fotsis T, Shevchenko A, Marselos M, Tsolas O and Messinis IE (1999) Purification of a candidate gonadotrophin surge attenuating factor from human follicular fluid. Hum Reprod 14,1449-1456.
156. Pigny P, Cortet-Rudelli C, Decanter C, Deroubaix D, Soudan B, Duhamel A and Dewailly D (2000) Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: Effects of being overweight and relevance to hyperandrogenism. Fertil Steril 73,972-977.
157. Plant TM and Shahab M (2002) Neuroendocrine mechanisms that delay and initiate puberty in higher primates. Physiol Behav 77,717-722.
158. Plant TM, Nakai Y, Belchetz P, Keogh E and Knobil E (1978) The sites of action of estradiol and phentolamine in the inhibition of the pulsatile, circhoral discharges of LH in the rhesus monkey (Macaca mulatta) Endocrinology 102,1015-1018.
159. Quyyumi SA, Pinkerton JV, Evans WS and Veldhuis JD (1993) Estradiol amplifies the amount of luteinizing hormone (LH) secreted in response to increasing doses of gonadotropin-releasing hormone by specifically augmenting the duration of evoked LH secretory events and hence their mass. J Clin Endocrinol Metab 76,594-600.
160. Ramey JW, Highsmith RF, Wilfinger WW and Baldwin DM (1987) The effects of gonadotropin-releasing hormone and estradiol on luteinizing hormone biosynthesis in cultured rat anterior pituitary cells. Endocrinology 120,1503-1513.
161. Richardson DW, Gordon K, Billiar RB and Little AB (1992) Chronic hyperestrogenemia: Lack of positive feedback action on gonadotropin-releasing hormone-induced luteinizing hormone release and dual site of negative feedback action. Endocrinology 130,1090-1096.
162. Rivier C and Vale W (1991) Effect of recombinant activin-A on gonadotropin secretion in the female rat. Endocrinology 129,2463-2465.
163. Rivier C, Rivier J and Vale W (1986) Inhibin-mediated feedback control of follicle-stimulating hormone secretion in the female rat. Science 234,205-208.
164. Rivier C, Schwall R, Mason A, Burton L, Vaughan J and Vale W (1991) Effect of recombinant inhibin on luteinizing hormone and follicle-stimulating hormone secretion in the rat. Endocrinology 128,1548-1554.
165. Roberts VJ, Barth S, El-Roeiy A and Yen SSC (1993) Expression of inhibin/ activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. J Clin Endocrinol Metab 77,1402-1410.
166. Robertson DM, Klein R, de Vos FL, McLachlan RI, Wettenhall RE, Hearn MT, Burger HG and de Kretser DM (1987) The isolation of polypeptides with FSH suppressing activity from bovine follicular fluid which are structurally different to inhibin. Biochem Biophys Res Commun 149,744-749.
167. Roseff SJ, Bangah ML, Kettel LM, Vale W, Rivier J, Burger HG and Yen SSC (1989) Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle. J Clin Endocrinol Metab 69,1033-1039.
168. Ross GT, Cargille CM, Lipsett MB, Rayford PL, Marshall JR, Strott CA and Rodbard D (1970) Pituitary and gonadal hormones in women during spontaneous and induced ovulatory cycles. Recent Prog Horm Res 26,1-62.
169. Roth JC, Kelch RP, Kaplan SL and Grumbach MM (1972) FSH and LH response to luteinizing hormone-releasing factor in prepubertal and pubertal children, adult males and patients with hypogonadotropic and hypertropic hypogonadism. J Clin Endocrinol Metab 35,926-930.
170. Santoro N, Banwell T, Tortoriello D, Lieman H, Adel T and Skurnick J (1998) Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women. Am J Obstet Gynecol 178,732-741.
171. Santoro N, Adel T and Skurnick JH (1999) Decreased inhibin tone and increased activin A secretion characterize reproductive aging in women. Fertil Steril 71,658-662.
172. Schreihofer DA, Stoler MH and Shupnik MA (2000) Differential expression and regulation of estrogen receptors (ERs) in rat pituitary and cell lines: Estrogen decreases ERalpha protein and estrogen responsiveness. Endocrinology 141,2174-2184.
173. Schreihofer DA, Rowe DF, Rissman EF, Scordalakes EM, Gustafsson JJA and Shupnik MA (2002) Estrogen receptor-alpha (ERalpha), but not ERbeta, modulates estrogen stimulation of the ERalpha-truncated variant, TERP-1. Endocrinology 143,4196-4202.
174. Shaw RW (1976) Tests of the hypothalamic-pituitary-ovarian axis. Clin Obstet Gynaecol 3,485-503.
175. Shoham Z, Schacter M, Loumaye E, Weissman A, MacNamee M and Insler V (1995) The luteinizing hormone surge - the final stage in ovulation induction: Modern aspects of ovulation triggering. Fertil Steril 64,237-251.
176. Simon JA, Bustillo M, Thorneycroft IH, Cohen SW and Buster JE (1987) Variability of midcycle estradiol positive feedback: Evidence for unique pituitary responses in individual women. J Clin Endocrinol Metab 1987,789-793.
177. Sluijmer AV, Heineman MJ, De Jong FH and Evers JL (1995) Endocrine activity of the postmenopausal ovary: The effects of pituitary down-regulation and oophorectomy. J Clin Endocrinol Metab 80,2163-2167.
178. Sollenberger MJ, Carlsen EC, Booth RA Jr, Johnson ML, Veldhuis JD and Evans WS (1990) Nature of gonadotropin-releasing hormone self-priming of luteinizing hormone secretion during the normal menstrual cycle. Am J Obstet Gynecol 163,1529-1534.
179. Soma KK, Sinchak K, Lakhter A, Schlinger BA and Micevych PE (2005) Neurosteroids and female reproduction: Estrogen increases 3beta-HSD mRNA and activity in rat hypothalamus. Endocrinology 146,4386-4390.
180. Sopelak VM and Hodgen GD (1984) Blockade of the estrogen-induced luteinizing hormone surge in monkeys: A nonsteroidal, antigenic factor in porcine follicular fluid. Fertil Steril 41,108-113.
181. Soules MR, Steiner RA, Clifton DK, Cohen NL, Aksel S and Bremner WJ (1984) Progesterone modulation of pulsatile luteinizing hormone secretion in normal women. J Clin Endocrinol Metab 58,378-383.
182. Soules MR, Battaglia DE and Klein NA (1998) Inhibin and reproductive aging in women. Maturitas 30,193-204.
183. Stouffer RL, Woodruff TK, Dahl KD, Hess DL, Mather JP and Molskness TA (1993) Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys. J Clin Endocrinol Metab 77,241-248.
184. Stouffer RL, Dahl KD, Hess DL, Woodruff TK, Mather JP and Molskness TA (1994) Systemic and intraluteal infusion of inhibin A or activin A in rhesus monkeys during the luteal phase of the menstrual cycle. Biol Reprod 50,888-895.
185. Tavaniotou A, Albano C, Smitz J and Devroey P (2001) Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix. Hum Reprod 16,663-667.
186. Tavoulari S, Frillingos S, Karatza P, Messinis IE and Seferiadis K (2004) The recombinant subdomain IIIB of human serum albumin displays activity of gonadotrophin surge-attenuating factor. Hum Reprod 19,849-858.
187. Taylor AE, Whitney H, Hall JE, Martin K and Crowley WF Jr (1995) Midcycle levels of sex steroids are sufficient to recreate the follicle-stimulating hormone but not the luteinizing hormone midcycle surge: Evidence for the contribution of other ovarian factors to the surge in normal women. J Clin Endocrinol Metab 80,1541-1547.
188. Taylor AE, Adams JM, Mulder JE, Martin KA, Sluss PM and Crowley WF Jr (1996) A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea. J Clin Endocrinol Metab 81,3615-3621.
189. Templeton A, Messinis IE and Baird DT (1986) Characteristics of ovarian follicles in spontaneous and stimulated cycles in which there was an endogenous luteinizing hormone surge. Fertil Steril 46,1113-1117.
190. Terasawa E, Noonan J and Bridson WE (1982) Anaesthesia with pentobarbitone blocks the progesterone-induced luteinizing hormone surge in the ovariectomized rhesus monkey. J Endocrinol 92,327-339.
191. Thorneycroft IH, Sribyatta B, Tom WK, Nakamura RM and Mishell DR Jr (1974) Measurement of serum LH, FSH, progesterone, 17-hydroxy-progesterone and estradiol-17beta levels at 4-hour intervals during the periovulatory phase of the menstrual cycle. J Clin Endocrinol Metab 39,754-758.
192. Tilbrook AJ, De Kretser DM and Clarke IJ (1993) Human recombinant inhibin A suppresses plasma follicle-stimulating hormone to intact levels but has no effect on luteinizing hormone in castrated rams. Biol Reprod 49,779-788.
193. Tilbrook AJ, Clarke IJ and de Kretser DM (1995) Human recombinant follistatin-288 suppresses plasma concentrations of follicle-stimulating hormone but is not a significant regulator of luteinizing hormone in castrated rams. Biol Reprod 53,1353-1358.
194. Tio S, Koppenaal D, Bardin CW and Cheng CY (1994) Purification of gonadotropin surge-inhibiting factor from Sertoli cell-enriched culture medium. Biochem Biophys Res Commun 199,1229-1236.
195. Tsai CC and Yen SSC (1971) The effect of ethinyl estradiol administration during early follicular phase of the cycle on the gonadotropin levels and ovarian function. J Clin Endocrinol Metab 33,917-923.
196. Tsonis CG, Messinis IE, Templeton AA, McNeilly AS and Baird DT (1988) Gonadotropic stimulation of inhibin secretion by the human ovary during the follicular and early luteal phase of the cycle. J Clin Endocrinol Metab 66,915-921.
197. Ueno N, Ling N, Ying SY, Esch F, Shimasaki S and Guillemin R (1987) Isolation and partial characterization of follistatin: A single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proc Natl Acad Sci USA 84,8282-8286.
198. Vale W, Rivier J, Vaughan J, McClintock R, Corrigan A, Woo W, Karr D and Spiess J (1986) Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 321,776-779.
199. van der Meer M, Hompes PG, Scheele F, Schoute E, Veersema S and Schoemaker J (1994) Follicle stimulating hormone (FSH) dynamics of low dose step-up ovulation induction with FSH in patients with polycystic ovary syndrome. Hum Reprod 9,1612-1617.
200. van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, de Jong FH and Themmen AP (2002) Serum anti-mullerian hormone levels: A novel measure of ovarian reserve. Hum Reprod 17,3065-3071.
201. van Santbrink EJ, Hop WC, van Dessel TJ, de Jong FH and Fauser BC (1995) Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. Fertil Steril 64,37-43.
202. Waldstreicher J, Santoro NF, Hall JE, Filicori M and Crowley WF Jr (1988) Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: Indirect evidence for partial gonadotroph desensitization. J Clin Endocrinol Metab 66,165-172.
203. Wallach EE, Root AW and Garcia CR (1970) Serum gonadotropin responses to estrogen and progestogen in recently castrated human females. J Clin Endocrinol Metab 31,376-381.
204. Waring DW and Turgeon JL (1992) A pathway for luteinizing hormone releasing-hormone self-potentiation: Cross-talk with the progesterone receptor. Endocrinology 130,3275-3282.
205. Wang CF, Lasley BL, Lein A and Yen SSC (1976) The functional changes of the pituitary gonadotrophs during the menstrual cycle. J Clin Endocrinol Metab 42,718-728.
206. Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, Kramer P, Fauser BC and Themmen AP (2004) Anti-Mullerian hormone expression pattern in the human ovary: Potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 10,77-83.
207. Wehrenberg WB, Wardlaw SL, Frantz AG and Ferin M (1982) beta-Endorphin in hypophyseal portal blood: Variations throughout the menstrual cycle. Endocrinology 111,879-881.
208. Weiss G, Skurnick JH, Goldsmith LT, Santoro NF and Park SJ (2004) Menopause and hypothalamic-pituitary sensitivity to estrogen. JAMA 292,2991-2996.
209. Welt CK, McNicholl DJ, Taylor AE and Hall JE (1999) Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab 84,105-111.
210. Welt CK, Martin KA, Taylor AE, Lambert-Messerlian GM, Crowley WF Jr, Smith JA, Schoenfeld DA and Hall JE (1997) Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: Evidence for FSH control of inhibin B in normal women. J Clin Endocrinol Metab 82,2645-2652.
211. Welt CK, Pagan YL, Smith PC, Rado KB and Hall JE (2003) Control of follicle-stimulating hormone by estradiol and the inhibins: Critical role of estradiol at the hypothalamus during the luteal-follicular transition. J Clin Endocrinol Metab 88,1766-1771.
212. Welt CK, Hall JE, Adams JM and Taylor AE (2005a) Relationship of estradiol and inhibin to the follicle-stimulating hormone variability in hypergonadotropic hypogonadism or premature ovarian failure. J Clin Endocrinol Metab 90,826-830.
213. Welt CK, Taylor AE, Fox J, Messerlian GM, Adams JM and Schneyer AL (2005b) Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis. J Clin Endocrinol Metab 90,5582-5587.
214. Westergaard LG, Laursen SB and Andersen CY (2000) Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum Reprod 15,1003-10008.
215. Winter JS and Faiman C (1973) The development of cyclic pituitary-gonadal function in adolescent females. J Clin Endocrinol Metab 37,714-718.
216. Xia L, Van Vugt D, Alston EJ, Luckhaus J and Ferin M (1992) A surge of gonadotropin-releasing hormone accompanies the estradiol-induced gonadotropin surge in the rhesus monkey. Endocrinology 131,2812-2820.
217. Yen SSC and Tsai CC (1971a) The effect of ovariectomy on gonadotropin release. J Clin Invest 50,1149-1153.
218. Yen SSC and Tsai CC (1971b) The biphasic pattern in the feedback action of ethinyl estradiol on the release of pituitary FSH and LH. J Clin Endocrinol Metab 33,882-887.
219. Yen SSC and Lein A (1976) The apparent paradox of the negative and positive feedback control system on gonadotropin secretion. Am J Obstet Gynecol 126,942-954.
220. Yin P, Kawashima K and Arita J (2002) Direct actions of estradiol on the anterior pituitary gland are required for hypothalamus-dependent lactotrope proliferation and secretory surges of luteinizing hormone but not of prolactin in female rats. Neuroendocrinology 75,392-401.
221. Young JR and Jaffe RB (1976) Strength-duration characteristics of estrogen effects on gonadotropin response to gonadotropin-releasing hormone in women. II. Effects of varying concentrations of estradiol. J Clin Endocrinol Metab 42,432-442.